131 related articles for article (PubMed ID: 20143432)
21. Does chemoradiotherapy improve outcomes for surgically resected adenocarcinoma of the stomach or esophagus?
Solomon NL; Cheung MC; Byrne MM; Zhuge Y; Franceschi D; Livingstone AS; Koniaris LG
Ann Surg Oncol; 2010 Jan; 17(1):98-108. PubMed ID: 19777191
[TBL] [Abstract][Full Text] [Related]
22. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
23. Is there under-treatment of pancreatic cancer? Evidence from a population-based study in Ireland.
Sharp L; Carsin AE; Cronin-Fenton DP; O'Driscoll D; Comber H
Eur J Cancer; 2009 May; 45(8):1450-9. PubMed ID: 19268569
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant treatments for resectable pancreatic cancer.
Ueno H; Kosuge T
J Hepatobiliary Pancreat Surg; 2008; 15(5):468-72. PubMed ID: 18836798
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemotherapy in stage III breast cancer.
Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
[TBL] [Abstract][Full Text] [Related]
27. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
[TBL] [Abstract][Full Text] [Related]
28. Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness.
Krzyzanowska MK; Weeks JC; Earle CC
J Clin Oncol; 2003 Sep; 21(18):3409-14. PubMed ID: 12972517
[TBL] [Abstract][Full Text] [Related]
29. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP
Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038
[TBL] [Abstract][Full Text] [Related]
30. Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130.
Martenson JA; Willett CG; Sargent DJ; Mailliard JA; Donohue JH; Gunderson LL; Thomas CR; Fisher B; Benson AB; Myerson R; Goldberg RM
J Clin Oncol; 2004 Aug; 22(16):3277-83. PubMed ID: 15249584
[TBL] [Abstract][Full Text] [Related]
31. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer.
Gross CP; McAvay GJ; Guo Z; Tinetti ME
Cancer; 2007 Jun; 109(12):2410-9. PubMed ID: 17510973
[TBL] [Abstract][Full Text] [Related]
32. Intraoperative radiotherapy in the combined-modality management of pancreatic cancer.
Schuricht AL; Spitz F; Barbot D; Rosato F
Am Surg; 1998 Nov; 64(11):1043-9. PubMed ID: 9798766
[TBL] [Abstract][Full Text] [Related]
33. Adenocarcinoma of the pancreatic head: a community teaching hospital's experience from 1982 to 1992.
Falk J; Keidan R; Rigo PK; Dmuchowski C
Am Surg; 1999 Jan; 65(1):15-8. PubMed ID: 9915524
[TBL] [Abstract][Full Text] [Related]
34. [Neoadjuvant therapy in pancreatic cancer].
Ji JF; Li ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):644-7. PubMed ID: 16274051
[TBL] [Abstract][Full Text] [Related]
35. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma.
Artinyan A; Anaya DA; McKenzie S; Ellenhorn JD; Kim J
Cancer; 2011 May; 117(10):2044-9. PubMed ID: 21523715
[TBL] [Abstract][Full Text] [Related]
37. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer.
Cronin DP; Harlan LC; Potosky AL; Clegg LX; Stevens JL; Mooney MM
Am J Gastroenterol; 2006 Oct; 101(10):2308-18. PubMed ID: 17032196
[TBL] [Abstract][Full Text] [Related]
38. [Surgical therapy of locally advanced and primary inoperable pancreatic carcinoma after neoadjuvant preoperative radiochemotherapy].
Rau HG; Wichmann MW; Wilkowski R; Heinemann V; Sackmann M; Helmberger T; Dühmke E; Schildberg FW
Chirurg; 2002 Feb; 73(2):132-7. PubMed ID: 11974476
[TBL] [Abstract][Full Text] [Related]
39. Quality of life after adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled study.
Morak MJ; Pek CJ; Kompanje EJ; Hop WC; Kazemier G; van Eijck CH
Cancer; 2010 Feb; 116(4):830-6. PubMed ID: 20029974
[TBL] [Abstract][Full Text] [Related]
40. Trajectory of care and use of multimodality therapy in older patients with pancreatic adenocarcinoma.
Parmar AD; Vargas GM; Tamirisa NP; Sheffield KM; Riall TS
Surgery; 2014 Aug; 156(2):280-9. PubMed ID: 24851723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]